Global Poliovirus Vaccine Market By Product Type (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)) And By End-Users/Application (Public, Private) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Poliovirus Vaccine market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Poliovirus Vaccine market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Poliovirus Vaccine industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Poliovirus Vaccine ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Poliovirus Vaccine market.

The following manufacturers are covered in this report:
  • Sanofi
  • GSK
  • Bibcol
  • Serum Institute
  • Tiantan Biological
  • IMBCA
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

The report estimates on the Poliovirus Vaccine market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Poliovirus Vaccine market report consist of all leading industry players, Poliovirus Vaccine business sections, company profile, revenue supply by Poliovirus Vaccine industry sections, global Poliovirus Vaccine market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Poliovirus Vaccine market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Poliovirus Vaccine market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Poliovirus Vaccine market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Poliovirus Vaccine market.

Report Opportunity: Global Poliovirus Vaccine Market

This report delivers an analytical examination of the Poliovirus Vaccine market summarized in broad sections such as
  1. Poliovirus Vaccine Market Summary
  2. Key Commercial Growths in the Poliovirus Vaccine Industry
  3. Market Dynamics Affecting the Poliovirus Vaccine Industry
  4. Important Market Trends and Future Development Scenario of the Poliovirus Vaccine Market
  5. Poliovirus Vaccine Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Poliovirus Vaccine Industry
  7. Positioning of Main Market Players in the Poliovirus Vaccine Industry
  8. Poliovirus Vaccine Market Revenue and Forecast, by Application, 2018 - 2028
  9. Poliovirus Vaccine Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Poliovirus Vaccine Market Revenue and Forecast, by Geography, 2018 - 2028
Poliovirus Vaccine Market Segmentation:

The report provides detailed examination of the Poliovirus Vaccine market on the basis of various segments such as type, application and end-use industry. The Poliovirus Vaccine market is segmented as follows:

Poliovirus Vaccine Market, by Type:
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
Poliovirus Vaccine Market, by Application:
  • Public
  • Private
Geographic Coverage

The report on the Poliovirus Vaccine market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Poliovirus Vaccine Market Revenue and Forecast
  • U.S.
  • Canada
Europe Poliovirus Vaccine Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Poliovirus Vaccine Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Poliovirus Vaccine Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Poliovirus Vaccine Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Poliovirus Vaccine Market Snapshot
          2.1.1. Global Poliovirus Vaccine Market By Type,2019
               2.1.1.1.Inactivated Polio Vaccine (IPV)
               2.1.1.2.Oral Polio Vaccine (OPV)
          2.1.2. Global Poliovirus Vaccine Market By Application,2019
               2.1.2.1.Public
               2.1.2.2.Private
          2.1.3. Global Poliovirus Vaccine Market By End-use,2019
          2.1.4. Global Poliovirus Vaccine Market By Geography,2019

3. Global Poliovirus Vaccine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Poliovirus Vaccine Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Poliovirus Vaccine Market Size (US$), By Type, 2018 – 2028

5. Global Poliovirus Vaccine Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Poliovirus Vaccine Market Size (US$), By Application, 2018 – 2028

6. Global Poliovirus Vaccine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Poliovirus Vaccine Market Size (US$), By End-use, 2018 – 2028

7. Global Poliovirus Vaccine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Poliovirus Vaccine Market Analysis, 2018 – 2028 
          7.2.1. North America Poliovirus Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Poliovirus Vaccine Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Poliovirus Vaccine Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Poliovirus Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Poliovirus Vaccine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Poliovirus Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Poliovirus Vaccine Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Poliovirus Vaccine Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Poliovirus Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Poliovirus Vaccine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Poliovirus Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Poliovirus Vaccine Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Poliovirus Vaccine Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Poliovirus Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Poliovirus Vaccine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Poliovirus Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Poliovirus Vaccine Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Poliovirus Vaccine Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Poliovirus Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Poliovirus Vaccine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Poliovirus Vaccine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Poliovirus Vaccine Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Poliovirus Vaccine Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Poliovirus Vaccine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Poliovirus Vaccine Providers
        8.4.1 Sanofi
                8.1.1 Business Description
                8.1.2 Sanofi Geographic Operations
                8.1.3 Sanofi Financial Information
                8.1.4 Sanofi Product Positions/Portfolio
                8.1.5 Sanofi Key Developments
        8.4.2 GSK
                8.2.1 Business Description
                8.2.2 GSK Geographic Operations
                8.2.3 GSK Financial Information
                8.2.4 GSK Product Positions/Portfolio
                8.2.5 GSK Key Developments
        8.4.3 Bibcol
                8.3.1 Business Description
                8.3.2 Bibcol Geographic Operations
                8.3.3 Bibcol Financial Information
                8.3.4 Bibcol Product Positions/Portfolio
                8.3.5 Bibcol Key Developments
        8.4.4 Serum Institute
                8.4.1 Business Description
                8.4.2 Serum Institute Geographic Operations
                8.4.3 Serum Institute Financial Information
                8.4.4 Serum Institute Product Positions/Portfolio
                8.4.5 Serum Institute Key Developments
        8.4.5 Tiantan Biological
                8.5.1 Business Description
                8.5.2 Tiantan Biological Geographic Operations
                8.5.3 Tiantan Biological Financial Information
                8.5.4 Tiantan Biological Product Positions/Portfolio
                8.5.5 Tiantan Biological Key Developments
        8.4.6 IMBCA
                8.6.1 Business Description
                8.6.2 IMBCA Geographic Operations
                8.6.3 IMBCA Financial Information
                8.6.4 IMBCA Product Positions/Portfolio
                8.6.5 IMBCA Key Developments
        8.4.7 Panacea Biotec Ltd
                8.7.1 Business Description
                8.7.2 Panacea Biotec Ltd Geographic Operations
                8.7.3 Panacea Biotec Ltd Financial Information
                8.7.4 Panacea Biotec Ltd Product Positions/Portfolio
                8.7.5 Panacea Biotec Ltd Key Developments
        8.4.8 Bio-Med
                8.8.1 Business Description
                8.8.2 Bio-Med Geographic Operations
                8.8.3 Bio-Med Financial Information
                8.8.4 Bio-Med Product Positions/Portfolio
                8.8.5 Bio-Med Key Developments
        8.4.9 Halfkin Bio-Pharmaceuticals
                8.9.1 Business Description
                8.9.2 Halfkin Bio-Pharmaceuticals Geographic Operations
                8.9.3 Halfkin Bio-Pharmaceuticals Financial Information
                8.9.4 Halfkin Bio-Pharmaceuticals Product Positions/Portfolio
                8.9.5 Halfkin Bio-Pharmaceuticals Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Poliovirus Vaccine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Poliovirus Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Poliovirus Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Poliovirus Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Poliovirus Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Poliovirus Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Poliovirus Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Poliovirus Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Poliovirus Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Poliovirus Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Poliovirus Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Poliovirus Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Poliovirus Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Poliovirus Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Poliovirus Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Poliovirus Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Poliovirus Vaccine: Market Segmentation 
FIG. 2 Global Poliovirus Vaccine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Poliovirus Vaccine Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Poliovirus Vaccine Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Poliovirus Vaccine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Poliovirus Vaccine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Poliovirus Vaccine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Poliovirus Vaccine Providers, 2019
FIG. 11 Global Poliovirus Vaccine Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Poliovirus Vaccine Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Poliovirus Vaccine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Poliovirus Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Poliovirus Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Poliovirus Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Poliovirus Vaccine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Poliovirus Vaccine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Poliovirus Vaccine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
2715

8688

OUR CLIENT